According to the latest KFF Health Tracking Poll, about 12% of the adult population has taken a GLP-1, like Ozempic or Wegovy
Regarding intracellular roGFP2-based structure-function analysis of glutaredoxins, we now showed that the GSSG-dependent oxidation of the fused glutaredoxin moiety (and not the glutathionylation of the roGFP2 moiety) is rate-limiting unless saturating GSSG concentrations are present
Gastrointestinal side effects like diarrhea, nausea, and bloating are very common, especially at the start of therapy
However, as of mid-2025, retatrutide has not received regulatory approval in the UK or elsewhere
Prioritize Sleep Essential for antioxidant production and hormonal balance
Only about 1-2% of your hair is in this phase at any given time